Erem Bilensoy

President at Hacettepe University

Location:
Sıhhiye Kampüsü, Ankara, Ankara, Turkey
Company:
Hacettepe University
HQ Phone:
+90 312 305 2026
Wrong Erem Bilensoy?

Last Updated 9/13/2017

General Information

Employment History

Consultancy Board  - TUBTAK Turkish Scientific and Technological Research Council

Education

Hacettepe University

M.Sc. degree  - 

Affiliations

President  - European Federation for Pharmaceutical Sciences

Member  - BA/BE Evaluation Commission

Member  - Bioavailability/Bioequivalence Evaluation Commission

Founder Member and Head  - EUFEPS Network

Board Member  - European Cyclodextrin Society

Web References  

Bilensoy, Erem - 7th BBBB International Conference on Pharmaceutical Sciences | 5-7 October 2017

Erem Bilensoy is full professor of pharmaceutical technology.
She graduated from Hacettepe University Faculty of Pharmacy in 1992. She obtained her double Ph.D. degree with a co-tutelle thesis between Université Paris-Sud and Hacettepe University in 2002 under the supervisions of Dominique Duchene and Atilla Hncal on the evaluation of amphiphilic ß-cyclodextrins modified on the primary face as novel excipients in the preparation of nanospheres and nanocapsules. She has been appointed as associate professor in 2007 and received full professor position in 2013. She is the author of more than 60 scientific articles, 11 international book chapters receiving more than 1100 citations with a current H-index of 21. She also worked as Editor of the book entitled "Cyclodextrins in the Field of Pharmaceutics, Cosmetics and Biomedicine: Current and Future Industrial Applications" published by John Wiley&Sons in 2012. Dr. Bilensoy served as Bioavailability/Bioequivalence Evaluation Commission member within Turkish Medicines and Medical Devices Agency between 2007-2012 and from December 2015 onwards. She was Vice Dean of Faculty of Pharmacy between 2010-2013. She is founder member and Head for EUFEPS Network on Nanomedicine and Board Member for European Cyclodextrin Society. Erem Bilensoy joined European Federation for Pharmaceutical Sciences EUFEPS Executive Committee in 2012 and was elected as President of EUFEPS starting from June 2015. She is also on the Consultancy Board for Projects on Nanobiotechnology at TUBTAK Turkish Scientific and Technological Research Council. She was recently elected as Vice Chairman for Hacettepe Technology Transfer Center Executive Committee on January 2016. Her current research interests include targeted nanoparticles in cancer therapy, cationic nanoparticles, cyclodextrin-based drug delivery, inkjet and 3D printed drug delivery systems, biomedical applications of nanoparticles and regulatory approaches on bioavailability/bioequivalence.

Read More
14th International Pharmaceutical Technology Symposium (IPTS 2008)

Erem Bilensoy graduated from Hacettepe University Faculty of Pharmacy in 1992.She received her M.Sc. degree with her thesis on the in vitro in vivo evaluation of rhGM-CSF loaded formulations for wound healing in the same university.She obtained her double Ph.D. degree with a co-tutelle thesis between Université Paris-Sud, France and Hacettepe University in 2002 on the evaluation of amphiphilic ß-cyclodextrins modified on the primary face as novel excipients in the preparation of nanospheres and nanocapsules.Erem Bilensoy worked as assistant professor between 2005-2007 and received her Associate Professor title in 2007.She is currently continuing her research work at the Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University.Dr. Bilensoy is serving as BA/BE Evaluation Commission member since 2007 and is the writer of 28 scientific articles, 6 book chapters and several oral and poster presentations.Her current research interests include nanoparticles in cancer therapy, cyclodextrin-based drug delivery and bioavailability/bioequivalence.Erem Bilensoy is married, with one child.

Read More
Scientists push international agenda for new medicines research | AJP

"The scientific aspects that need to be addressed and developed to fully exploit the systems approach to drug development are a realistic and solid integration of pharmacogenetics and pharmacogenomics with drug delivery and drug design, incorporating engineering approaches to facilitate reproducible and cost-effective manufacturing of future medicines that are personalised," said Prof Erem Bilensoy, president of the European Federation of Pharmaceutical Sciences

Read More

Browse ZoomInfo’s Directories